The effects of adrenergic blocking agents on passive cutaneous anaphylaxis reactions in the rat.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001202:Ascitic Fluid / Q000032:analysis; D002199:Capillary Permeability / Q000187:drug effects; D002848:Chromatography, DEAE-Cellulose; D003983:Dibenzylchlorethamine / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology; D006632:Histamine / Q000032:analysis; D006636:Histamine Release; D007106:Immune Sera; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G; D007271:Injections, Intradermal; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects*; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D012710:Serum Albumin, Bovine; D013565:Sympatholytics / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D007106:Immune Sera; D007074:Immunoglobulin G; D013565:Sympatholytics; D012710:Serum Albumin, Bovine; D003983:Dibenzylchlorethamine; D006632:Histamine; D004837:Epinephrine